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Abstract
Background: Metastatic involvement of pericardium producing cardiac tamponade is rare. When
o c c u r s  i t  i s  m a i n l y  f r o m  t h e  l u n g ,  b r e a s t  a n d the neoplasms of the lymphoreticular system.
Hematogenous spread of parotid adenocarcinoma to heart is extremely rare and only two cases
have been reported in literature so far.
Case presentation: We report an unusual case of a patient with adenocarcinoma of the parotid
gland, which presented with cardiac tamponade and was treated urgently with pericardial drainage
and intrapericardial injection of cisplatin.
Conclusions: Our case demonstrates the possibility of metastatic pericardial involvement and
cardiac tamponade in patients with parotid adenocarcinoma. The patient was successfully treated
with pericardial drainage and intrapericardial injection of chemotherapeutic agent to control
recurrent pericardial effusion.
Introduction
A variety of malignant diseases have been reported to
metastasize to the pericardium. The ones most commonly
reported include bronchial carcinoma, breast cancer,
leukemia, Hodgkin's disease, non-Hodgkin's lymphoma,
melanoma, gastrointestinal tumors and sarcomas.
Metastatic involvement of the pericardium may occur
from either direct invasion by an adjacent primary tumor
or by lymphatic or hematogenous spread. We report here
a case of hematogenous metastasis to pericardium from
adenocarcinoma of the parotid gland.
Case Report
A 61-year-old woman was admitted with a palpable right
parotid mass and peripheral facial nerve palsy. She under-
went a radical total parotidectomy with a subsequent
diagnosis of high-grade adenocarcinoma of the parotid
gland (T2N2BM0 – Stage IV AJCC 1997 [1]. Postoperatively
she was treated with adjuvant radiotherapy (parotid bed
and neck nodes – 60 Gy over 30 fractions) and 3 cycles of
chemotherapy (docetaxel, 100 mg/m2 over 1 hour I.V.
injection every 3 weeks) and was followed-up on a routine
outpatient basis.
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Seven months later she was readmitted with a 3-day his-
tory of dyspnea, dry cough, chest pain, fatigue and lower
extremity edema. She was afebrile with normal laboratory
blood tests. Physical examination revealed facial plethora,
orthopnea, tachypnea, jugular venous distention, periph-
eral cyanosis, distant heart sounds, decreased breath
sounds at both lung bases and a blood pressure 90/55
mm Hg. Admission chest X-ray showed increased cardiot-
horacic ratio without pulmonary congestion (Figure 1).
The electrocardiogram revealed sinus tachycardia, low
QRS voltage and presence of total electrical alternans
involving both atrial and ventricular complexes. An emer-
Chest roentgenogram showing increased cardiac shadow due  to pericardial effusion Figure 1
Chest roentgenogram showing increased cardiac shadow due 
to pericardial effusion.
CT scan of the thorax showing pericardial effusion Figure 2
CT scan of the thorax showing pericardial effusion. 1. Lung, 
2. Pericardial fat, 3. Pericardial effusion, 4. Heart, 5. Thoracic 
aorta.
Aspiration cytology smear of centrifuged pericardial fluid  showing malignant cells (Hematoxylin and Eosin × 400) Figure 3
Aspiration cytology smear of centrifuged pericardial fluid 
showing malignant cells (Hematoxylin and Eosin × 400).
Normal chest roentgenogram 10 days after the intrapericar- dial chemotherapy Figure 4
Normal chest roentgenogram 10 days after the intrapericar-
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gency echocardiogram disclosed massive pericardial effu-
sion with right atrial and ventricular collapse. A thoracic
CT scan demonstrated a large pericardial effusion without
any evidence of intrathoracic lymphadenopathy, superior
vena cava obstruction or metastases (Figure 2). Diagnostic
right heart catheterization revealed a central venous pres-
sure of 21 cm H2O, a right ventricular pressure of 40/21
mm Hg and a pulmonary artery pressure of 22 mm Hg. A
diagnosis of cardiac tamponade was established. Pericar-
diocentesis was performed and 750 ml of serosanguinous
pericardial fluid were aspirated. Cytologic examination
was positive for malignant cells having features of adeno-
carcinoma (Figure 3). The patient tolerated the procedure
well without complications and experienced immediate
clinical improvement. After five days, when daily accumu-
lation of pericardial fluid decreased below 30 ml, we
instilled 30 mg of cisplatin into the pericardial cavity and
the catheter was removed. The patient underwent chest X-
rays and three echocardiograms during the next 10 days
which revealed no recurrent pericardial effusion (Figure 4
and 5). There were no complications related to the cispla-
tin installation. Her condition improved and she was dis-
charged. She is alive and disease free at 5 months of
follow-up.
Discussion
Malignant involvement of the heart or pericardium is not
uncommon in patients with advanced cancer. The preva-
lence of combined metastasis to the pericardium and
heart ranges from 0.1% to 21%. The most common malig-
nancies involving the heart or pericardium include lung,
breast, leukemia, Hodgkin's and non-Hodgkin's lym-
phoma, melanoma, gastrointestinal primaries and sarco-
mas [2].
The increase in pericardial fluid seen in malignant pericar-
dial effusions is usually due to obstruction of lymphatic
and venous drainage of the heart and this disturbs the
level of intrapericardial pressure depending on the rate of
fluid accumulation, pericardial compliance and intravas-
cular volume. Mediastinal nodal involvement, which is
frequently seen with lung and breast cancer, disturbs lym-
Post treatment 2-D and M-mode echocardiogram exhibiting no fluid accumulation and normal LV function Figure 5
Post treatment 2-D and M-mode echocardiogram exhibiting no fluid accumulation and normal LV function.Publish with BioMed Central    and   every 
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phatic drainage from the heart and pericardium through
the cardiac nodes.
Our case demonstrates pericardial involvement and car-
diac tamponade in a patient with parotid cancer. Accord-
ing to the international literature, two cases of parotid
adenocarcinoma involving the pericardium have been
described [3,4]. Becker et al reported a unique case of
malignant pericardial effusion secondary to metastatic
mucoepidermoid carcinoma in a patient previously
treated for mucoepidermoid carcinoma of the parotid
gland and subsequently found to have hypernephroma of
the kidney. Surgical intervention and pericardial window
formation was ultimately necessary in this case. In the sec-
ond case Sulkes et al., reported a metastatic pericardial
involvement due to parotid adenocarcinoma but without
cardiac tamponade and right heart congestive signs. In our
case the patient presented with cardiac tamponade and
was successfully treated with pericardiocentesis and intra-
pericardial administration of cisplatin.
The acute treatment of malignant pericardial effusion
with cardiac tamponade involves the prompt removal of
pericardial fluid by pericardiocentesis usually under
echocardiographic guidance. The long-term management
however remains controversial. Radiotherapy has been
considered effective however it is not used any more. The
creation of a pericardial window has been shown to be
quite effective and has until recently been considered to
be the treatment of choice for malignant pericardial effu-
sion. The procedure requires left anterolateral thoracot-
omy or subxiphoid approach under general anesthesia
and can be associated with significant morbidity and mor-
tality in an already debilitated patient.
Intrapericardial administration of sclerozing agents such
as tetracycline, 5 FU, bleomycin, cisplatin, and talc has
been used for the palliative treatment of malignant peri-
cardial effusions. Intrapericardial tetracycline has been
used extensively with successful long-term control of effu-
sions. Unfortunately, the use of tetracycline has been asso-
ciated with several complications including arrhythmias,
severe pain and fever [5]. We favor intrapericardial instil-
lation of cisplatin, which has been associated with
minimal side effects (bleomycin has the same results as
that of cisplatin [6]) [7,8][9].
In our case there were no complications except for a mild
fever (up to 37.5°C) for 48 hours after the instillation.
The patient is alive, free of primary disease-related symp-
toms with no local or distant recurrence on the follow-up.
There were no recurrences of pericardial effusion or com-
pressive-constrictive physiology on repeated
echocardiograms.
In summary, this rare case suggests that a malignant peri-
cardial effusion should be considered in the patient with
parotid adenocarcinoma who develops cardiac tampon-
ade. Cytologic examination of aspirated cardiac pericar-
dial fluid can confirm the diagnosis. Intrapericardial
instillation of sclerosing agents should be considered,
especially in patients in whom control of recurrent effu-
sion would significantly add to quality of life or life
expectancy.
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